Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

be

5 posts
NNovartis
Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform
Read More

Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform

  • 2026-07-06
Potential first-in-class N-myristoyltransferase inhibitor (NMTi) ADC payload with a differentiated mechanism of actionCombines oncology expertise of Novartis with…
SSwitzerland
Possible Reasons Behind the Cancellation of Switzerland Talks
Read More

Possible Reasons Behind the Cancellation of Switzerland Talks

  • 2026-06-20
Islam Times – Perhaps the biggest analytical mistake would be to view the cancellation of the Switzerland talks…
GGeneva
Iran Deputy FM: US MoU Signing Set for Friday in Geneva
Read More

Iran Deputy FM: US MoU Signing Set for Friday in Geneva

  • 2026-06-16
Islam Times – Iran’s Deputy Foreign Minister for Legal and International Affairs, Kazem Gharibabadi, said the memorandum of…
NNovartis
Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
Read More

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

  • 2026-03-27
– Acquisition brings together Excellergy’s differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development expertise of…
GGeneva
Good Progress Made in Iran-US Talks in Geneva: Araghchi
Read More

Good Progress Made in Iran-US Talks in Geneva: Araghchi

  • 2026-02-27
Islam Times – Iranian Foreign Minister Abbas Araghchi said after the third round of Iran-US talks that the…
Switzerland
www.europesays.com